Difference between revisions of "O-806"

From Self-sufficiency
Jump to: navigation, search
m (Adding category Category:Organobromides (using HotCat))
 
m (1 revision)
 
(No difference)

Latest revision as of 21:09, 21 September 2010

O-806
240px
Systematic (IUPAC) name
(6aR)-3-(6-bromohex-2-ynyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
Identifiers
PubChem CID 10549140
Chemical data
Formula C22H27BrO2
Molar mass 403.352 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

O-806 is a drug which is a cannabinoid derivative that is used in scientific research. It is described as a mixed agonist/antagonist at the cannabinoid receptor CB1, meaning that it acts as an antagonist when co-administered alongside a more potent CB1 agonist, but exhibits weak partial agonist effects when administered by itself.[1][2]

References

  1. Griffin, G.; Wray, E.; Rorrer, W.; Crocker, P.; Ryan, W.; Saha, B.; Razdan, R.; Martin, B.; Abood, M. (1999). "An investigation into the structural determinants of cannabinoid receptor ligand efficacy". British journal of pharmacology. 126 (7): 1575–1584. doi:10.1038/sj.bjp.0702469. PMC 1565939Freely accessible. PMID 10323589.  edit
  2. Griffin, G.; Wray, E.; Martin, B.; Abood, M. (1999). "Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum". British journal of pharmacology. 128 (3): 684–688. doi:10.1038/sj.bjp.0702806. PMC 1571656Freely accessible. PMID 10516649.  edit